Automated Variable Pressure Insufflation for Migraine

N/A

Waitlist Available

Research Sponsored by Nocira, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 hours post treatment

Summary

This trial is testing a new migraine treatment against a sham treatment. Participants will be randomly assigned to one of the two treatments and followed for 24 hours after treatment.

Eligible Conditions

Migraine

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 hours post treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 hours post treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Pain Freedom Rates - active

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Active TreatmentExperimental Treatment1 Intervention

The AVPI device software is set in "active mode" which delivers the therapy to the subject. Neither the subject or the investigator is aware of which mode is being used.

Group II: Sham treatmentPlacebo Group1 Intervention

The AVPI device software is set in "sham mode" which does not deliver the therapy to the subject. Neither the subject or the investigator is aware of which mode is being used.

Do I qualify?Apply below to find out